The next new target in leukemia: The embryonic stem cell gene SALL4.
about
SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancerTranscriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.A New Indole Derivative Decreased SALL4 Gene Expression in Acute Promyelocytic Leukemia Cell Line (NB4)SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway.Stemness-Related Markers in Cancer.SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis.
P2860
The next new target in leukemia: The embryonic stem cell gene SALL4.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The next new target in leukemia: The embryonic stem cell gene SALL4.
@en
type
label
The next new target in leukemia: The embryonic stem cell gene SALL4.
@en
prefLabel
The next new target in leukemia: The embryonic stem cell gene SALL4.
@en
P2093
P2860
P1476
The next new target in leukemia: The embryonic stem cell gene SALL4.
@en
P2093
P2860
P304
P356
10.4161/23723548.2014.969169
P577
2014-01-01T00:00:00Z